impact factor, citescore
logo
 

2001 Vol.19, N°1 - Suppl.22 - Table of contents

Nimesulide: beyond COX-2

Full Papers

CER1051
2001,19,1,Suppl.22
Pg. 0001-0002

Free to view

Introduction to "Nimesulide: Beyond COX-2"
T.D. Warner

Rheumatology Abstract

Rheumatology Article

 

CER1052
2001,19,1,Suppl.22
Pg. 0003-0005

Free to view

Differential regulation of interleukin-1b-induced cyclooxygenase-2 gene expression by nimesulide in human synovial fibroblasts
J.A. Di Battista, H. Fahmi, Y. He, M. Zhang, J. Martel-Pelletier, J.-P. Pelletier

Rheumatology Abstract

Rheumatology Article

 

CER1053
2001,19,1,Suppl.22
Pg. 0007-0011

Free to view

Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death
P. Mukherjee, C. Rachita, P.S. Aisen, G.M. Pasinetti

Rheumatology Abstract

Rheumatology Article

 

CER1054
2001,19,1,Suppl.22
Pg. 0013-0015

Free to view

Inhibition of gastric acid secretion by nimesulide: A possible factor in its gastric tolerability
I.A. Tavares, F. Borrelli, N.J. Welsh

Rheumatology Abstract

Rheumatology Article

 

CER1055
2001,19,1,Suppl.22
Pg. 0017-0020

Free to view

The role of NSAIDS in psoriatic arthritis: Evidence from a controlled study with nimesulide
P. Sarzi-Puttini, S. Santandrea, L. Boccassini, B. Panni, I. Caruso

Rheumatology Abstract

Rheumatology Article

 

CER1056
2001,19,1,Suppl.22
Pg. 0021-0025

Free to view

Nimesulide, a balanced drug for the treatment of osteoarthritis
E.C. Huskisson

Rheumatology Abstract

Rheumatology Article